Insulet
PODD
#1918
Rank
NZ$18.81 B
Marketcap
NZ$271.30
Share price
2.09%
Change (1 day)
-51.29%
Change (1 year)
Categories
Insulet Corporation is an American company that develops and sells medical devices used for the administration of insulin.

EPS for Insulet (PODD)

EPS in 2026 (TTM): NZ$7.34

According to Insulet's latest financial reports the company's current EPS (TTM) is NZ$7.51. In 2024 the company made an earnings per share (EPS) of NZ$10.62 an increase over its 2023 EPS that were of NZ$5.24.

EPS history for Insulet from 2011 to 2026

Annual EPS

Year EPS Change
2026 (TTM)NZ$7.34
2024NZ$10.62102.71%
2023NZ$5.244114.29%
2022NZ$0.12-69.57%
2021NZ$0.41109.09%
2020NZ$0.20-38.89%
2019NZ$0.32200%
2018NZ$0.11-113.04%
2017NZ-$0.82-9.8%
2016NZ-$0.91-60.47%
2015NZ-$2.2938.71%
2014NZ-$1.6512.05%
2013NZ-$1.47-23.15%
2012NZ-$1.92-12.2%
2011NZ-$2.18

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
NZ$15.51 106.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
NZ$5.54-26.29%๐Ÿ‡บ๐Ÿ‡ธ USA
Medtronic
MDT
NZ$7.24-3.55%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Eli Lilly
LLY
NZ$53.06 606.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Tandem Diabetes Care
TNDM
NZ-$1.65-121.99%๐Ÿ‡บ๐Ÿ‡ธ USA
ICU Medical
ICUI
NZ$2.13-71.63%๐Ÿ‡บ๐Ÿ‡ธ USA
DexCom
DXCM
NZ$4.60-38.77%๐Ÿ‡บ๐Ÿ‡ธ USA